TCT 2021: Late-breaking Science Video Collection

Published: 09 November 2021

  • Views:

    Views Icon 2343

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise and insightful preview of the late-breaking science presented at TCT 2021.

Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

View from the Thoraxcenter: Preview of the Late-Breaking Trials

2 sessions
What's Hot at TCT 2021: View from the Thoraxcenter Watch now
View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up Watch now

Part 2

Expert Interviews

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
11 sessions
FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG Watch now
iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR Watch now
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB Watch now
CHOICE-CLOSURE: Plug-based Vs Suture-based Large-bore Vascular Closure Watch now
TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients Watch now
SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB Watch now
Intrepid TMVR: Results Show Improved NYHA Class at 30 Days Watch now
12Mo Results Comparing PCB With SCB Show No Difference in Clinical Incidences Watch now
RADIANCE-HTN Trio: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant Hypertension Watch now
BIO-RESORT: 5Y Outcomes Watch now
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG Watch now

Faculty Biographies

David Kandzari

David Kandzari

Director of Interventional Cardiology and Chief Scientific Officer

Dr David Kandzari obtained his undergraduate degree from Duke University School of Medicine then completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. 

Dr Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews. Dr Kandzari is board certified in internal medicine and cardiovascular diseases and is certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His…

View full profile